Subjects must not be taking any enzyme-inducing anti-epileptic drugs EIAED or other drugs that are potent inducers of CYP3A4 function rifampicin rifabutin phenytoin carbamazepine phenobarbitol and St. John 's Wort If patients were previously on EIAEDs and these have been discontinued patients must have been off the agent for at least 7 days prior to registration 